Actionable Stock Market Trading Newswire. Built for Traders, by Traders. All news is property of their respective owners.
HomeNewsfeedsUPDATE: Clovis Oncology Says Meeting With FDA To Discuss Plans For SNDA Submission For First-Line Maintenance Treatment For Women With Advanced Ovarian Cancer
UPDATE: Clovis Oncology Says Meeting With FDA To Discuss Plans For SNDA Submission For First-Line Maintenance Treatment For Women With Advanced Ovarian Cancer
Core Scientific shares are trading higher Tuesday after the company announced the signing of a series of 12-year contracts with CoreWeave. Here's a look at the details.